Literature DB >> 19669866

Release of PLGA-encapsulated dexamethasone from microsphere loaded porous surfaces.

G J S Dawes1, L E Fratila-Apachitei, B S Necula, I Apachitei, G J Witkamp, J Duszczyk.   

Abstract

The aim of the present study was to investigate the morphology and function of a drug eluting metallic porous surface produced by the immobilization of poly lactide-co-glycolide microspheres bearing dexamethasone onto plasma electrolytically oxidized Ti-6Al-7Nb medical alloy. Spheres of 20 microm diameter were produced by an oil-in-water emulsion/solvent evaporation method and thermally immobilized onto titanium discs. The scanning electron microscopy investigations revealed that the size distribution and morphology of the attached spheres had not changed significantly. The drug release profiles following degradation in phosphate buffered saline for 1000 h showed that, upon immobilisation, the spheres maintained a sustained release, with a triphasic profile similar to the non-attached system. The only significant change was an increased release rate during the first 100 h. This difference was attributed to the effect of thermal attachment of the spheres to the surface.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19669866      PMCID: PMC2805798          DOI: 10.1007/s10856-009-3846-6

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  21 in total

1.  In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices.

Authors:  T Hickey; D Kreutzer; D J Burgess; F Moussy
Journal:  J Biomed Mater Res       Date:  2002-08

2.  An asymmetric coating composed of gelatin and hydroxyapatite for the delivery of water insoluble drug.

Authors:  Junwu Xiao; Yingchun Zhu; Yanyan Liu; Yi Zeng; Fangfang Xu
Journal:  J Mater Sci Mater Med       Date:  2008-11-20       Impact factor: 3.896

3.  Size effect of PLGA spheres on drug loading efficiency and release profiles.

Authors:  G J S Dawes; L E Fratila-Apachitei; K Mulia; I Apachitei; G-J Witkamp; J Duszczyk
Journal:  J Mater Sci Mater Med       Date:  2009-01-22       Impact factor: 3.896

4.  PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions.

Authors:  E Vega; F Gamisans; M L García; A Chauvet; F Lacoulonche; M A Egea
Journal:  J Pharm Sci       Date:  2008-12       Impact factor: 3.534

Review 5.  Improving protein therapeutics with sustained-release formulations.

Authors:  S D Putney; P A Burke
Journal:  Nat Biotechnol       Date:  1998-02       Impact factor: 54.908

6.  The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres.

Authors:  Guobao Wei; Qiming Jin; William V Giannobile; Peter X Ma
Journal:  Biomaterials       Date:  2007-01-08       Impact factor: 12.479

7.  Short term in vivo biocompatibility testing of biodegradable poly(D,L-lactide)--growth factor coating for orthopaedic implants.

Authors:  Britt Wildemann; Andre Sander; Philipp Schwabe; Martin Lucke; Ulrich Stöckle; Michael Raschke; Norbert P Haas; Gerhard Schmidmaier
Journal:  Biomaterials       Date:  2005-06       Impact factor: 12.479

8.  Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone.

Authors:  S L Cheng; J W Yang; L Rifas; S F Zhang; L V Avioli
Journal:  Endocrinology       Date:  1994-01       Impact factor: 4.736

9.  A study on in vitro degradation behavior of a poly(glycolide-co-L-lactide) monofilament.

Authors:  Meng Deng; Gavin Chen; Daniel Burkley; Jack Zhou; Dennis Jamiolkowski; Yunmei Xu; Robert Vetrecin
Journal:  Acta Biomater       Date:  2008-04-11       Impact factor: 8.947

10.  Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels.

Authors:  J Liu; S M Zhang; P P Chen; L Cheng; W Zhou; W X Tang; Z W Chen; C M Ke
Journal:  J Mater Sci Mater Med       Date:  2007-08-01       Impact factor: 3.896

View more
  4 in total

1.  Cell-Mediated Dexamethasone Release from Semi-IPNs Stimulates Osteogenic Differentiation of Encapsulated Mesenchymal Stem Cells.

Authors:  Sooneon Bae; Ho-Joon Lee; Jeoung Soo Lee; Ken Webb
Journal:  Biomacromolecules       Date:  2015-08-17       Impact factor: 6.988

2.  Co-Delivery of Dexamethasone and Captopril by α8 Integrin Antibodies Modified Liposome-PLGA Nanoparticle Hybrids for Targeted Anti-Inflammatory/Anti-Fibrosis Therapy of Glomerulonephritis.

Authors:  Liuting Zhou; Zhenyan Ye; E Zhang; Li Chen; Yitong Hou; JuChun Lin; Fenglan Huang; Zhixiang Yuan
Journal:  Int J Nanomedicine       Date:  2022-03-30

Review 3.  Surgical Applications of Materials Engineered with Antimicrobial Properties.

Authors:  David P Perrault; Ayushi Sharma; Jessica F Kim; Geoffrey C Gurtner; Derrick C Wan
Journal:  Bioengineering (Basel)       Date:  2022-03-26

4.  Novel Utilization of Therapeutic Coatings Based on Infiltrated Encapsulated Rose Bengal Microspheres in Porous Titanium for Implant Applications.

Authors:  Francesca Accioni; Giovanna Rassu; Belén Begines; Luisa Marleny Rodríguez-Albelo; Yadir Torres; Ana Alcudia; Elisabetta Gavini
Journal:  Pharmaceutics       Date:  2022-06-12       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.